Alacepril Inhibitor

Name: Alacepril Inhibitor; MyBioSource
Brand: MyBioSource
SKU: MBS5758674
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5758674

Alacepril is a relatively novel angiotensin-converting enzyme inhibitor, used as an antihypertensive More details

Please Inquire

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

Alacepril, Inhibitor

Full Product Name

Alacepril

Product Synonym Names

Cetapril; DU-1219

Form/Format

Solid. Powder

Purity/Purification

98.19%

Preparation and Storage

Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent

Molecular Weight

406.50

Solubility

<1mg/ml refers to the product slightly soluble or insoluble

Formula

C20H26N2O5S

SMILES

CC(=O)SCC(C)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)O

CAS Number

74258-86-9

Target & IC50

Angiotensin Receptor

In Vitro

treatment with alacepril improves functional status and exercise capacity in patients with mild-to-moderate CHF. Neurohormones were favourably influenced by alacepril therapy, with significant decreases in plasma aldosterone, ANP and BNP levels[1].

Product Categories/Family for Alacepril, inhibitor

Endocrinology/Hormones; RAAS

Product References and Citations for Alacepril, inhibitor

Kinugawa T, Osaki S, Kato M, et al. Effects of the angiotensin-converting enzyme inhibitor alacepril on exercise capacity and neurohormonal factors in patients with mild-to-moderate heart failure[J]. Clin Exp Pharmacol Physiol, 2002, 29(12):1060-1065.
Kinugawa T, Osaki S, Kato M, et al. Effects of the angiotensin-converting enzyme inhibitor alacepril on exercise capacity and neurohormonal factors in patients with mild-to-moderate heart failure[J]. Clin Exp Pharmacol Physiol, 2002, 29(12):1060-1065.
Yasutomo H, Kensuke N, Nobuyuki K, et al. Effects of the angiotensin-converting enzyme inhibitor alacepril in dogs with mitral valve disease[J]. Journal of Veterinary Medical Science, 2018.
Yasutomo H, Kensuke N, Nobuyuki K, et al. Effects of the angiotensin-converting enzyme inhibitor alacepril in dogs with mitral valve disease[J]. Journal of Veterinary Medical Science, 2018.

Other Notes

Small volumes of Alacepril, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Alacepril purchase

MBS5758674 is an inhibitor targeting Alacepril.